Michael L. Lipton

https://assets.montefioreeinstein.org/profiles/images/Lipton_Michael_MD_420x504.jpg

First Name

Michael

Last Name

Lipton

NPI

1366535502

Faculty ID

148

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p><strong>Michael L. Lipton, M.D., Ph.D., F.A.C.R.</strong><br />Dr. Lipton, a neuroradiologist and neuroscientist, is Associate Director of the Gruss Magnetic Resonance Research Center at Einstein and &nbsp;Medical Director of MRI Services for Montefiore Health, both in New York. He divides his professional time between the clinical practice of neuroradiology, teaching and research. Dr. Lipton&rsquo;s research broadly addresses the use of advanced noninvasive imaging technology to reveal heretofore-inaccessible substrates of brain dysfunction, particularly in the realms of behavior and cognition. More specifically, his research program has focused for nearly a decade on detecting and characterizing the effects of mild brain injury (AKA concussion). Specific areas of emphasis at present include the understanding of inter-individual differences in the manifestations of brain injury and the cumulative effects of repetitive subconcussive injury in sports. Dr. Lipton&rsquo;s work on the impact of subconcussive &ldquo;heading&rdquo; on brain structure and function in amateur soccer players, funded by the Dana Foundation and the National Institutes of Health, has been reported extensively in the press worldwide.</p>

Research Areas

Research Profile

CHAM Provider

Off

Professional Title

Clinical Focus

<p>Dr. Lipton develops and applies advanced quantitative MRI to enhance characterization of brain disease in patients with persistent symptoms related to traumatic brain injury and other disorders that are not adequately visualized using conventional imaging approaches</p>

Research Focus

<p>Dr. Lipton applies advanced imaging technology to characterize the effects of trauma on behavior and cognition. His work on repeated subconcussive head impacts in soccer players has been reported extensively in the press worldwide.</p>

Elsevier Profile

Biography

<p>Michael L. Lipton, MD, PhD, FACR, is the Medical Director of MRI Services and an Attending Radiologist at Montefiore. He is also a Professor of Radiology, Psychiatry and Behavioral Sciences at our Albert Einstein College of Medicine. Dr. Lipton has been a member of the Montefiore team since 1997, with a clinical focus on developing advanced quantitative MRI to enhance characterization of brain diseases. He works primarily with patients who suffer persistent symptoms related to traumatic brain injury and other disorders that are not easily identified with conventional imaging approaches. </p><p>Dr. Lipton received his Doctor of Medicine from Boston University in 1990. He continued his studies by attending our Albert Einstein College of Medicine, where he received his Master of Science with Distinction and his Doctor of Philosophy in Neuroscience. His postgraduate training began with an internship in internal medicine at Brookdale Hospital Medical Center completed in 1991. Over 5 years, Dr. Lipton completed a residency and chief residency in diagnostic radiology, followed by a 2-year fellowship in neuroradiology at Montefiore, completing his postgraduate training in 1997. </p><p>Dr. Lipton has completed substantial research on repeated subconcussive head impacts in sports, particularly in soccer players. His work on this topic has been reported on extensively in the press worldwide. Dr. Lipton?s other research focuses mainly on the brain and has been shared in a number of presentations internationally, as well as published in numerous books and papers. </p><p>In 2017, Dr. Lipton received the Distinguished Investigator Award from the Academy of Radiology and Biomedical Imaging Research. Dr. Lipton is board certified by the American Board of Radiology, is a Fellow of the American College of Radiology and is a member of numerous professional societies, including the the American Medical Association, and the American Society of Neuroradiology. </p>

Is Open Scheduling

Off

Elissa G. Yozawitz

https://assets.montefioreeinstein.org/profiles/images/Yozawitz_Elissa_MD_2x.jpg

First Name

Elissa

Last Name

Yozawitz

NPI

1316269707

Faculty ID

13026

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Pediatric neurology, epilepsy, neonatal neurology.</p>

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

Dr. Yozawitz focuses on the management of neonatal neurology and pediatric epilepsy, particularly children and adolescents with difficult-to-treat seizures.&nbsp; She specializes in a variety of neurological conditions diagnosed in the newborn period, including hypoxic-ischemic encephalopathy, stroke, and seizures.&nbsp; She has expertise in EEG and advanced medical treatments. She provides care from the neonatal period through adolescence.

Research Focus

Dr. Yozawitz&rsquo;s research is focused on neonatal seizures and early-life epilepsies, including infantile spasms.&nbsp; She is involved in multicenter studies to improve the diagnosis, treatment, and outcomes for children with epilepsy.&nbsp; She is also involved in assessing EEG changes during anesthesia.

Elsevier Profile

EMR ID

4929

Biography

<p>Elissa G. Yozawitz, MD, is Director of Neonatal Neurology at Children&rsquo;s Hospital at Montefiore Einstein and Professor of Neurology and Pediatrics at our Albert Einstein College of Medicine. Dr. Yozawitz focuses on the neurological management of children, from the neonatal period through adolescence, particularly those with difficult-to-treat seizures. She also specializes in the diagnosis and treatment of hypoxic-ischemic encephalopathy, stroke and seizures in the newborn. Dr. Yozawitz&rsquo;s expertise includes electroencephalography (EEG) and state-of-the-art treatments.</p><p>After obtaining a Bachelor of Arts in psychology and in health and society from the University of Rochester in 2001, Dr. Yozawitz earned a Doctor of Medicine from the State University of New York Upstate Medical University in 2005. She completed a pediatric residency at Schneider Children&rsquo;s Hospital in 2007, followed by a residency in pediatric neurology at Montefiore Einstein in 2010. Dr. Yozawitz remained at Montefiore Einstein to complete a fellowship in clinical neurophysiology in 2011.</p><p>Dr. Yozawitz&rsquo;s research focuses on improving the identification and efficacy of treating early-life epilepsies, including infantile spasms. Her research also explores EEG changes during anesthesia. Dr. Yozawitz participated in multicenter studies, functioned as site principal investigator and co-investigator for multiple research projects, presented her research findings at national and international scientific meetings, published in numerous peer-reviewed journals and authored several book chapters. She served as a reviewer for medical journals including <em>Epilepsia, Epileptic Disorders, Neurology</em> and the <em>New England Journal of Medicine</em>, among others. For several years, Dr. Yozawitz participated in the work of international committees tasked to revise nosology and treatment guidelines for neonatal and childhood epilepsy.</p><p>Dr. Yozawitz is board certified by the American Board of Psychiatry and Neurology in Epilepsy and Neurology, with special certification in Child Neurology. She is a member of the American Academy of Neurology, the American Epilepsy Society and the Child Neurology Society. Dr. Yozawitz repeatedly has been named in Castle Connolly&rsquo;s &ldquo;Regional Top Doctor,&rdquo; &ldquo;Top Doctors: New York Metro Area.&rdquo; She additionally has been listed in <em>New York Magazine&rsquo;s</em> &ldquo;Top Doctors&rdquo; for multiple years.</p>

Is Open Scheduling

Off

Michael Yee

https://assets.montefioreeinstein.org/profiles/images/13771-michael-yee.jpg

First Name

Michael

Last Name

Yee

NPI

1699971085

Faculty ID

13771

CMO Specialties

Clinical Terms

Employment Status

Per Diem

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

5456

Is Open Scheduling

Off

Danny Woo

https://assets.montefioreeinstein.org/profiles/images/physphoto/Woo_Danny_MD_420x504.jpg

First Name

Danny

Last Name

Woo

NPI

1639272057

Faculty ID

3618

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Languages

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

3880

Is Open Scheduling

Off

Daniel A. Weiser

https://assets.montefioreeinstein.org/profiles/images/Weiser_Daniel_MD_2x.jpg

First Name

Daniel

Last Name

Weiser

NPI

1225239700

Faculty ID

13846

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p><span style="text-decoration: underline;"><strong>Childhood cancer research laboratory</strong></span></p>
<p>Our laboratory is focused on childhood cancer research with a goal of elucidating the underlying biology of the most aggressive malignancies. In such patients with typically incurable cancer, we are striving to identify new approaches to and types of treatment. We have multiple ongoing projects:</p>
<p><strong>+ Identification of biologic drivers of ultra-high-risk neuroblastoma</strong>. Neuroblastoma is one of the most common and deadly childhood cancers. Despite intensive research, there are limited therapeutic strategies for patients with <em>de novo </em>chemotherapy resistance that leads to particularly poor outcomes. We have been studying neuroblastoma since 2009 and are identifying additional biologic drivers of highly lethal tumors.</p>
<p>We compare tumor features from patients with early death from tumor progression compared to those with a maintained complete response. We assess unique histo-morphologic and proteomic features and computationally integrate these data with genomic and transcriptomic datasets to develop a combined predictor of primary refractory disease. Patients with this entity require non-standard and/or intensified treatment. Oncogenic drivers are being characterized in the lab which will facilitate strategies for novel pharmacologic intervention.</p>
<p><strong>+ Characterization of neuroblastoma development from neural crest cells</strong>.&nbsp; We are studying pathways and interactions that results in uncontrolled cell proliferation early in neuroblastoma development with an ultimate goal of identifying new targets and approaches for pharmacologic intervention.</p>
<p><strong>+ Evaluation of novel combinatorial targeted therapeutic approaches in neuroblastoma</strong>.&nbsp; With expected outcomes lagging behind those of more common childhood cancers, children with neuroblastoma require new approaches to treatment. Our lab works with multiple international clinical and research consortium groups to perform preclinical studies that substantiate human clinical trials.&nbsp;</p>
<p><strong>+ Detection of circulating tumor DNA in osteosarcoma</strong>. With no reliable non-invasive approach for disease monitoring during and after treatment, we are applying cutting edge next-generation sequencing approaches to identify solid tumors with a blood-based &ldquo;liquid&rdquo; biopsies. This will allow clinicians to assess tumor responsiveness to chemotherapy and predict likelihood of recurrence.</p>
<p><strong>+ Assessment of accelerated aging using miRNA-seq in survivors of childhood cancer</strong>. Chemotherapy has many untoward effects on healthy cells and leads to many signs of accelerated aging in children treated for cancer. Using a known microRNA &ldquo;aging&rdquo; signature discovered at Albert Einstein College of Medicine, we are studying what causes this phenotype in childhood cancer, with a goal of offering improved intervention to minimize long-term toxicity of treatment.</p>
<p><strong><span style="text-decoration: underline;">Physician Summary</span></strong></p>
<p>Daniel A. Weiser, MD, is board-certified in pediatric hematology/oncology with clinical expertise in neuroblastoma and other tumors of the adrenal glands, kidneys, liver, and gonads. He is the medical director of the intra-abdominal solid tumor program at the Children&rsquo;s Hospital at Montefiore and brings together a highly specialized multi-disciplinary care team to provide comprehensive treatment for diverse pediatric malignancies. In addition, Dr. Weiser directs a childhood cancer research laboratory that focuses on the identification of new targeted agents for cancer therapy, especially in the treatment of rare and aggressive malignancies such as neuroblastoma. His research goals are to understand the role of certain genes in the risk, development, and treatment of cancer. The approaches taken and agents studied hold promise for improving management of all patients with solid tumors.</p>
<p>Dr. Weiser participates in the efforts of a number of professional organizations including the Children&rsquo;s Oncology Group (COG), American Association for Cancer Research (AACR), American Society of Clinical Oncology (ASCO), Advances in Neuroblastoma Research Association (ANRA), National Pediatric Cancer Foundation (NPCF), and the American Academy of Pediatrics (AAP). He has received numerous awards including the Brigid Leventhal Special Merit Award from ASCO and the Conquer Cancer Foundation, and a prestigious K12 from the National Cancer Institute for the training of the next generation of physician-scientists in pediatric cancer. Dr. Weiser is actively involved in teaching and mentorship of trainees, and takes great pride in providing advanced and compassionate care to his patients and their families.</p>
<p><strong>Clinical Expertise</strong></p>
<ul>
<li>Neuroblastoma (adrenal tumors)</li>
<li>Wilms tumor (renal tumors)</li>
<li>Hepatoblastoma (liver tumors)</li>
<li>Germ cell tumors (including testicular and ovarian tumors)</li>
<li>Thyroid and other rare tumors</li>
<li>Experimental therapeutics</li>
<li>Cancer genetics and biomarkers</li>
</ul>
<p><strong>Board Certifications</strong></p>
<ul>
<li>Pediatrics</li>
<li>Pediatric Hematology/Oncology</li>
</ul>
<p><strong>Professional Education</strong></p>
<ul>
<li>M.D. &ndash; Stony Brook University, NY</li>
<li>Residency &ndash; Children&rsquo;s Hospital of NY-Presbyterian, Columbia University, NY</li>
<li>Chief Residency &ndash; Children&rsquo;s Hospital of NY-Presbyterian, Columbia University, NY</li>
<li>Fellowship &ndash; The Children&rsquo;s Hospital of Philadelphia, PA</li>
</ul>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

DR. Weiser's clinical focuses are neuroblastoma and adrenal tumors, Wilms tumor and other kidney (renal) tumors, hepatoblastoma, and other liver tumors, germ cell tumors (including testicular and ovarian tumors), Thyroid and other rare tumors, experimental therapeutics, and cancer genetics and biomarkers.&nbsp;

Research Focus

Dr. Weiser&rsquo;s research goals are to understand the role of certain genes in the risk, development, and treatment of cancer. The approaches taken and agents studied hold promise in the treatment of all solid tumors. Dr. Weiser&rsquo;s laboratory focuses on childhood cancer research with a goal of elucidating the underlying biology of the most aggressive malignancies. He has multiple ongoing projects, such as identification of biologic drivers of neuroblastoma at ultra-high risk for treatment failure, characterization of neuroblastoma development from neural crest cells, and evaluation of novel combinatorial targeted therapeutic approaches in neuroblastoma, among others.

Elsevier Profile

EMR ID

5755

Biography

<p>Daniel A. Weiser, MD, is a Medical Director of the Intra-abdominal Solid Tumor Program in the Pediatrics Hematology/Oncology department at Children&rsquo;s Hospital at Montefiore. He is also Associate Professor in the Pediatrics and Genetics departments at the Albert Einstein College of Medicine. His clinical focuses are neuroblastoma and adrenal tumors, Wilms tumor and other kidney (renal) tumors, hepatoblastoma and other liver tumors, germ cell tumors (including testicular and ovarian tumors), Thyroid and other rare tumors, experimental therapeutics, and cancer genetics and biomarkers. Dr. Weiser is actively involved in teaching and mentorship of trainees and takes great pride in his active participation in patient care.</p><p>Dr. Weiser received his Bachelor of Science in Neurobiology in 1995 at Haverford College, PA. In 2004, he received his Doctor of Medicine at Stony Brook University School of Medicine, NY. He is currently earning his Master of Science in Translational Research at the University of Pennsylvania. He began a residency in Pediatrics at the New York-Presbyterian, Columbia University in 2007. Dr. Weiser then completed a three-year fellowship in Pediatric Hematology/Oncology at The Children&rsquo;s Hospital of Philadelphia. </p><p>Dr. Weiser&rsquo;s research goals are to understand the role of certain genes in the risk, development, and treatment of cancer. The approaches taken and agents studied hold promise in the treatment of all solid tumors. Dr. Weiser&rsquo;s laboratory focuses on childhood cancer research with a goal of elucidating the underlying biology of the most aggressive malignancies. He has multiple ongoing projects, such as identification of biologic drivers of neuroblastoma at ultra-high risk for treatment failure, characterization of neuroblastoma development from neural crest cells, and evaluation of novel combinatorial targeted therapeutic approaches in neuroblastoma, among others. His research has been published in many reviewed journals. </p><p>Dr. Weiser participates in the efforts of a number of professional organizations including the Children&rsquo;s Oncology Group (COG), American Association for Cancer Research (AACR), American Society of Clinical Oncology (ASCO), and the American Academy of Pediatrics (AAP). He has received many awards including the Brigid Leventhal Special Merit Award through ASCO, and he has been awarded a prestigious K12 from the NCI for the training of the next generation of physician-scientists in pediatric cancer.</p><p>He is board certified in Pediatric Hematology/Oncology and General Pediatrics.</p>

Is Open Scheduling

Off

Jacqueline Weingarten-Arams

https://assets.montefioreeinstein.org/profiles/images/physphoto/Weingarten_Jacqueline_MD_420x504.jpg

First Name

Jacqueline

Last Name

Weingarten-Arams

NPI

1558447409

Faculty ID

4831

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Areas

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Elsevier Profile

Lab Website Link

EMR ID

3961

Biography

<p>Jacqueline Weingarten-Arams, MD, is an attending physician and Professor, Pediatrics at Montefiore Einstein. Dr. Weingarten-Arams&rsquo; pediatric critical care expertise focuses on cardiac critical care, acute hypoxemic respiratory failure, nutrition in critical illness and energy expenditure, cardiopulmonary resuscitation (quality CPR) and extracorporeal life support (ECMO).</p><p>After obtaining her Bachelor of Science in nutritional biochemistry at Cornell University in 1982, Dr. Weingarten-Arams earned her Doctor of Medicine at the same institution in 1986. She then completed her pediatric residency at Columbia University in 1990, where she was Chief Resident in her final year. Following this, Dr. Weingarten-Arams completed a fellowship in pediatric critical care medicine at New York Hospital Cornell University Medical College in 1996.</p><p>Dr. Weingarten-Arams research focus includes the use of deliberate simulated practice in improving outcomes in pediatric critical illness, pediatric resuscitation and pediatric airway management. Her other projects involve chronic critical illness, bioethics in pediatric critical care and oxidative injury in respiratory failure. She has been principal investigator and co-investigator on several research projects, and her work has been shared through numerous peer-reviewed publications and invited presentations.</p><p>Dr. Weingarten-Arams is a Diplomate of the National Board of Medical Examiners and the American Board of Pediatrics. She is a Fellow of the American Academy of Pediatrics and the American College of Chest Physicians. She is also a member of several professional organizations, including the American Medical Association, the Pediatric Cardiac Intensive Care Society and the Society of Critical Care Medicine. Dr. Weingarten-Arams has been named in Castle Connolly&rsquo;s &ldquo;Top Doctors: New York Metro Area&rdquo; for multiple years. In 2006, she was inducted into the Leo M. Davidoff Society and in 2019, Dr. Weingarten-Arams won the William Obrinsky Award for Excellence in Medical Student Education.</p>

Is Open Scheduling

Off

Victoria Vapnyar

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/dd685560-3db5-11ec-b813-25aca5adcea8.jpg

First Name

Victoria

Last Name

Vapnyar

NPI

1740556133

Faculty ID

17135

CMO Specialties

Clinical Terms

Employment Status

Per Diem

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

101619

Is Open Scheduling

Off

Jamie T. Twaite

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/bc5b6200-e560-11ed-a217-395eb2a75f2f.jpg

First Name

Jamie

Last Name

Twaite

NPI

1003390972

Faculty ID

16241

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. Twaite&rsquo;s clinical focus is on the neuropsychological evaluation and rehabilitation of individuals with cognitive and emotional concerns related to neurologic, medical, and psychiatric illness. She has a particular interest in the diagnosis and management of dementias and acquired brain injury(ABI), as well as in the rehabilitation of of spinal cord injury (both with and without concurrent ABI).<quillbot-extension-portal></quillbot-extension-portal>

Research Focus

Dr. Twaite&rsquo;s research interests include cognitive and emotional functioning following stroke, TBI, and other acquired brain injury, as well as in individuals with Parkinson&rsquo;s disease and in healthy populations, such as musicians.<quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

EMR ID

16191

Biography

<p>Jamie Twaite, PhD, is a Neuropsychologist, Co-Director, Burke Rehabilitation Hospital&rsquo;s Concussion Management Program, Director, Neuropsychology Externship and Assistant Professor, Physical Medicine and Rehabilitation at Montefiore Einstein. Her clinical focus is on the neuropsychological evaluation and rehabilitation of individuals with cognitive and emotional concerns related to neurologic, medical and psychiatric illnesses. She has a particular interest in the diagnosis and management of dementia and acquired brain injury (ABI), as well as in the rehabilitation of spinal cord injury (both with and without concurrent ABI).</p><p>After completing her Master of Psychology at Columbia University in 2008, Dr. Twaite pursued her Doctor of Philosophy in psychology at City University of New York (CUNY), earning the degree in 2016. That same year, she completed an APA-accredited predoctoral internship in clinical psychology-adult neuropsychology track with the Henry Ford Health System. She then went on to complete her postdoctoral fellowship in clinical neuropsychology with the Institute of Living, Hartford Hospital, with focused training in the assessment of memory disorders/dementias, acquired brain injuries, and severe and persistent mental illness.</p><p>Dr. Twaite&rsquo;s research interests include cognitive and emotional functioning following stroke, traumatic brain injury (TBI) and other acquired brain injury in individuals with Parkinson&rsquo;s disease as well as in healthy populations, such as in musicians. Her work has been published in numerous peer-reviewed journals and she has given paper and poster presentations at scientific meetings nationally and internationally. Dr. Twaite is a reviewer for the <em>Journal of Clinical and Experimental Neuropsychology</em> and the <em>Journal of Psycholinguistic Research</em>.</p><p>Dr. Twaite is a member of several professional associations, including the American Psychological Association (APA), the Society for Clinical Neuropsychology and the International Neuropsychological Society. In 2013, Dr. Twaite received the Graduate Center Doctoral Student Research Grant from CUNY.</p>

Is Open Scheduling

Off

Mark A. Thomas

https://assets.montefioreeinstein.org/profiles/images/Thomas_Mark_A_MD_420x504.jpg

First Name

Mark

Last Name

Thomas

NPI

1215021571

Faculty ID

6011

CMO Specialties

Clinical Terms

Employment Status

Per Diem

Patient Type

Adult

Department

Gender

Male

Email

Titles

Locations

Education and Trainings

Research Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

3524

Is Open Scheduling

Off

Michael L. Swerdlow

https://assets.montefioreeinstein.org/profiles/images/6792-michael swerdlow.jpg

First Name

Michael

Last Name

Swerdlow

NPI

1225113541

Faculty ID

6792

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Michael Swerdlow graduated from The University Of Pennsylvania School of Medicine.&nbsp; He did a medical residency at Mt. Sinai Hospital in New York.&nbsp; He then completed the neurology residency at Albert Einstein College of Medicine in The Bronx.&nbsp;&nbsp; He then did a fellowship Neuromuscular diseases at the N.I.H. in Bethesda.&nbsp; He joined the faculty at Montefiore Hospital and Albert Einstein College.&nbsp; He presently is a&nbsp; Professor of Clinical Neurology.&nbsp;&nbsp; He has a large faculty practice with Dr. David Kaufman as "K and S."&nbsp;&nbsp; He teaches residents and supervises the Neurology Clinic and is involved in CME teaching.&nbsp; Special areas of interest include muscle disorders, Myasthenia Gravis, Multiple Sclerosis and disorders of the spine.</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

3518

Is Open Scheduling

Off